The Journal of the Society of Stroke on Korean Medicine (대한중풍순환신경학회지)
- Volume 17 Issue 1
- /
- Pages.55-66
- /
- 2016
- /
- 2466-0248(pISSN)
- /
- 2466-0272(eISSN)
A Case Report of the Beneficial Effects of Chunghyul-Plus in Dyslipidemia Patients
청혈플러스로 호전된 이상지질혈증 환자 4례 보고
- Jung, Eun Sun (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Kim, Hyun Tae (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Choi, Koh Eun (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Oh, Jeong Min (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Cho, Hyun Kyoung (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Yoo, Ho Ryong (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Kim, Yoon Sik (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
- Seol, In Chan (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University)
- 정은선 (대전대학교 한의과대학 심계내과학교실) ;
- 김현태 (대전대학교 한의과대학 심계내과학교실) ;
- 최고은 (대전대학교 한의과대학 심계내과학교실) ;
- 오정민 (대전대학교 한의과대학 심계내과학교실) ;
- 조현경 (대전대학교 한의과대학 심계내과학교실) ;
- 유호룡 (대전대학교 한의과대학 심계내과학교실) ;
- 김윤식 (대전대학교 한의과대학 심계내과학교실) ;
- 설인찬 (대전대학교 한의과대학 심계내과학교실)
- Published : 2016.12.01
Abstract
Dyslipidemia is a major risk factor for cardiovascular accidents (CVA) and heart disease, especially the ischemic type. Lowering of serum low-density lipoprotein cholesterol (LDL-C) levels is a primary measure for preventing atherosclerosis. Many medications are available for the treatment of dyslipidemia; however, these drugs have some side effects. Therefore, we treated dyslipidemia patients with Chunghyul-plus. Before treatment, patients' levels of total cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), and LDL-C were measured on an empty stomach. Thereafter, patients were administered 1000 mg (2 capsules) of Chunghyul-plus two or three times a day for 2 weeks. After treatment with Chunghyul-plus, patients' serum triglyceride, LDL-C, and total cholesterol levels decreased. The results of this study suggest that Chunghyul-plus might be useful in the treatment of dyslipidemia.